8-K current report · filed Aug 26, 2026

GYRE THERAPEUTICS, INC. (GYRE) 8-K Current Report: August 26, 2026

Item 7.01GYRE overview

Short answer

GYRE THERAPEUTICS, INC. (GYRE) filed an 8-K current report with the SEC on August 26, 2026 reporting Item 7.01 (Regulation FD Disclosure). Updated corporate presentation released August 26, 2026, providing investors with the company’s latest strategic and operational messaging.

GYRE THERAPEUTICS, INC. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Updated corporate presentation released August 26, 2026, providing investors with the company’s latest strategic and operational messaging
  • Exhibit 99.1 contains the substantive presentation and should be reviewed for pipeline, clinical, or financing updates

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other GYRE THERAPEUTICS, INC. 8-K filings

Get the next GYRE 8-K as it lands

Follow GYRE for push alerts, or ask the research agent what this filing means.